NCT07548008

Brief Summary

This study aims to compare the clinical and radiographic success of two commonly used pulpotomy agents, ferric sulfate (FS) and sodium hypochlorite (NaOCl), in vital primary molars. Pulpotomy is a widely used vital pulp therapy procedure in pediatric dentistry to preserve primary teeth until their natural exfoliation. The study will include children aged 4-9 years who previously received pulpotomy treatment using either FS or NaOCl at Marmara University Faculty of Dentistry. No additional treatment will be performed as part of this study. Patients will be followed during routine clinical visits at 6, 12, and 24 months. Clinical outcomes such as pain, mobility, and infection, as well as radiographic findings including resorption and radiolucency, will be evaluated. The results of this study are expected to provide evidence for the effectiveness of these materials and support clinical decision-making in pediatric dental practice.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for all trials

Timeline
9mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Aug 2025Feb 2027

Study Start

First participant enrolled

August 10, 2025

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

April 17, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 23, 2026

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 10, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2027

Last Updated

April 23, 2026

Status Verified

August 1, 2025

Enrollment Period

1.5 years

First QC Date

April 17, 2026

Last Update Submit

April 17, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical and Radiographic Success Rate of Pulpotomy

    The primary outcome is the clinical and radiographic success of pulpotomy-treated primary teeth. Clinical success is defined as the absence of pain, mobility, fistula, abscess, or tenderness to percussion. Radiographic success is defined as the absence of internal or external resorption, periapical or furcal radiolucency, and other pathological findings.

    24 months

Secondary Outcomes (2)

  • Clinical Success Rate

    6, 12, and 24 months

  • Radiographic Success Rate

    6, 12, and 24 months

Study Arms (2)

Ferric Sulfate Group

Children aged 4-9 years who received pulpotomy treatment in vital primary molars using 15.5% ferric sulfate as part of routine clinical care.

Sodium Hypochlorite Group

Children aged 4-9 years who received pulpotomy treatment in vital primary molars using 5% sodium hypochlorite as part of routine clinical care.

Eligibility Criteria

Age4 Years - 9 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of children aged 4-9 years who were treated at the Department of Pediatric Dentistry, Marmara University Faculty of Dentistry. These participants had previously undergone pulpotomy treatment in vital primary molars using either ferric sulfate or sodium hypochlorite as part of routine clinical care. The study includes patients with available clinical records and diagnostic radiographs, and who are followed during routine recall visits at 6, 12, and 24 months. No additional interventions are performed as part of the study.

You may qualify if:

  • Children aged 4-9 years
  • Patients who received pulpotomy treatment in vital primary molars using 15.5% ferric sulfate or 5% sodium hypochlorite between January and April 2025 Availability of preoperative diagnostic periapical radiographs of adequate quality
  • Complete clinical records of the pulpotomy procedure
  • Patients who attended or agreed to attend follow-up visits at 6, 12, and 24 months
  • Cases in which the treatment protocol and materials used were clearly documented

You may not qualify if:

  • Incomplete or poor-quality clinical and/or radiographic records
  • Presence of systemic diseases (e.g., immunosuppression, uncontrolled systemic conditions)
  • History of allergy or hypersensitivity to ferric sulfate or sodium hypochlorite
  • Teeth with intraoperative complications (e.g., perforation, uncontrolled bleeding, or change in treatment plan)
  • Teeth with pulp exposure due to trauma (only caries-related cases included)
  • Patients who did not attend follow-up visits or attended only one follow-up visit

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Marmara University

Istanbul, Turkey (Türkiye)

Location

Related Publications (1)

  • Coll JA, Seale NS, Vargas K, Marghalani AA, Al Shamali S, Graham L. Primary Tooth Vital Pulp Therapy: A Systematic Review and Meta-analysis. Pediatr Dent. 2017 Jan 15;39(1):16-123.

    PMID: 28292337BACKGROUND

MeSH Terms

Conditions

Dental Caries

Condition Hierarchy (Ancestors)

Tooth DemineralizationTooth DiseasesStomatognathic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
research assistant

Study Record Dates

First Submitted

April 17, 2026

First Posted

April 23, 2026

Study Start

August 10, 2025

Primary Completion (Estimated)

February 10, 2027

Study Completion (Estimated)

February 10, 2027

Last Updated

April 23, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared due to privacy and confidentiality considerations. The study involves pediatric participants, and all data are anonymized and handled in accordance with ethical guidelines and data protection regulations.

Locations